Open AccessDynamic changes and multiplication rate of white blood cell count may direct the timing of cytoreduction chemotherapy during induction treatment in newly diagnosed acute promyelocytic leukemia with low‑intermediate risk
Author(s) -
Junping Wen,
Fang Xu,
Qin Zhou,
Hong Hu,
Yiping Liu,
Jing Su,
Ya Zhang,
Wen Qu,
Lin Shi
Publication year - 2021
Publication title -
molecular and clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 7
eISSN - 2049-9469
pISSN - 2049-9450
DOI - 10.3892/mco.2021.2274
Subject(s) - acute promyelocytic leukemia , white blood cell , medicine , gastroenterology , chemotherapy , leukemia , induction chemotherapy , arsenic trioxide , immunology , biology , retinoic acid , apoptosis , biochemistry , gene